02/13/2020
9:36 AM | Alexion Pharmaceuticals (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G
| |
02/12/2020
10:01 AM | Alexion Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A
| |
02/10/2020
4:00 PM | Alexion Pharmaceuticals (Issuer)
HANTSON LUDWIG (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/10/2020
3:58 PM | Alexion Pharmaceuticals (Issuer)
Goff Brian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/10/2020
3:57 PM | Alexion Pharmaceuticals (Issuer)
Franchini Indrani Lall (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/10/2020
3:56 PM | Alexion Pharmaceuticals (Issuer)
Bazarko Daniel (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/04/2020
5:30 AM | Alexion Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
01/30/2020
5:34 AM | Alexion Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/28/2020
8:47 AM | Alexion Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/13/2020
5:18 AM | Alexion Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/10/2020
9:25 AM | Alexion Pharmaceuticals (Subject)
FMR LLC (Filed by)
| Form SC 13G/A
| |
12/04/2019
5:52 PM | Alexion Pharmaceuticals (Issuer)
Bazarko Daniel (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/04/2019
5:38 PM | Alexion Pharmaceuticals (Issuer)
Bazarko Daniel (Reporting)
| Form 3/A
| |
12/04/2019
5:36 PM | Alexion Pharmaceuticals (Issuer)
SARIN ARADHANA (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/02/2019
3:37 PM | Alexion Pharmaceuticals (Issuer)
Carino Tanisha (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/05/2019
3:44 PM | Alexion Pharmaceuticals (Issuer)
Carino Tanisha (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
10/23/2019
6:56 AM | Alexion Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/23/2019
6:13 AM | Alexion Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/21/2019
4:27 PM | Alexion Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/16/2019
7:53 AM | Alexion Pharmaceuticals (Filer)
| Form DEFA14A
| |
10/16/2019
7:50 AM | Alexion Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/17/2019
3:12 PM | Alexion Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/24/2019
7:00 AM | Alexion Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/24/2019
5:46 AM | Alexion Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/15/2019
4:01 PM | Alexion Pharmaceuticals (Issuer)
Clancy Paul J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/02/2019
3:41 PM | Alexion Pharmaceuticals (Issuer)
Franchini Indrani Lall (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/24/2019
3:45 PM | Alexion Pharmaceuticals (Issuer)
SARIN ARADHANA (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2019
5:39 PM | Alexion Pharmaceuticals (Issuer)
ORLOFF JOHN J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2019
5:38 PM | Alexion Pharmaceuticals (Issuer)
Goff Brian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2019
5:37 PM | Alexion Pharmaceuticals (Issuer)
LAW ANNE-MARIE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2019
5:35 PM | Alexion Pharmaceuticals (Issuer)
Franchini Indrani Lall (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/30/2019
4:16 PM | 667, L.P. (Reporting)
Alexion Pharmaceuticals (Issuer)
Baker Bros. Advisors LLC (0001580575) (Reporting)
BAKER BROS. ADVISORS LP (Reporting)
Baker Brothers Life Sciences LP (Reporting)
BAKER FELIX (Reporting)
BAKER JULIAN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2019
3:58 PM | 667, L.P. (Reporting)
Alexion Pharmaceuticals (Issuer)
Baker Bros. Advisors LLC (0001580575) (Reporting)
BAKER BROS. ADVISORS LP (Reporting)
Baker Brothers Life Sciences LP (Reporting)
BAKER FELIX (Reporting)
BAKER JULIAN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2019
3:42 PM | Alexion Pharmaceuticals (Issuer)
Brennan David R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2019
3:37 PM | Alexion Pharmaceuticals (Issuer)
Nader Francois (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2019
3:36 PM | Alexion Pharmaceuticals (Issuer)
Mollen John T (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2019
3:34 PM | Alexion Pharmaceuticals (Issuer)
Dunsire Deborah (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2019
3:27 PM | Alexion Pharmaceuticals (Issuer)
Reinsdorf Judith A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2019
3:03 PM | Alexion Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/25/2019
7:51 AM | Alexion Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/25/2019
5:54 AM | Alexion Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/26/2019
7:36 AM | Alexion Pharmaceuticals (Filer)
| Form DEFA14A
| |
03/26/2019
7:32 AM | Alexion Pharmaceuticals (Filer)
| Form DEF 14A
| |
03/05/2019
7:24 PM | Alexion Pharmaceuticals (Issuer)
HANTSON LUDWIG (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2019
7:23 PM | Alexion Pharmaceuticals (Issuer)
SARIN ARADHANA (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2019
7:21 PM | Alexion Pharmaceuticals (Issuer)
Franchini Indrani Lall (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2019
7:19 PM | Alexion Pharmaceuticals (Issuer)
Goff Brian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2019
7:18 PM | Alexion Pharmaceuticals (Issuer)
ORLOFF JOHN J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2019
7:16 PM | Alexion Pharmaceuticals (Issuer)
Bazarko Daniel (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2019
7:14 PM | Alexion Pharmaceuticals (Issuer)
Chiniara Ellen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2019
7:13 PM | Alexion Pharmaceuticals (Issuer)
Clancy Paul J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2019
7:12 PM | Alexion Pharmaceuticals (Issuer)
LAW ANNE-MARIE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2019
4:45 PM | Alexion Pharmaceuticals (Issuer)
SARIN ARADHANA (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2019
4:43 PM | Alexion Pharmaceuticals (Issuer)
Chiniara Ellen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2019
4:42 PM | Alexion Pharmaceuticals (Issuer)
ORLOFF JOHN J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2019
4:40 PM | Alexion Pharmaceuticals (Issuer)
LAW ANNE-MARIE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2019
4:39 PM | Alexion Pharmaceuticals (Issuer)
HANTSON LUDWIG (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2019
4:37 PM | Alexion Pharmaceuticals (Issuer)
Clancy Paul J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2019
4:36 PM | Alexion Pharmaceuticals (Issuer)
Goff Brian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2019
4:35 PM | Alexion Pharmaceuticals (Issuer)
Franchini Indrani Lall (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2019
4:33 PM | Alexion Pharmaceuticals (Issuer)
Bazarko Daniel (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2019
3:30 PM | Alexion Pharmaceuticals (Issuer)
Bazarko Daniel (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2019
8:10 PM | Alexion Pharmaceuticals (Issuer)
Bazarko Daniel (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/19/2019
6:29 PM | Alexion Pharmaceuticals (Issuer)
Bazarko Daniel (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/19/2019
6:27 PM | Alexion Pharmaceuticals (Issuer)
Bazarko Daniel (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
02/19/2019
5:31 PM | Alexion Pharmaceuticals (Issuer)
SARIN ARADHANA (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
02/14/2019
12:48 PM | Alexion Pharmaceuticals (Subject)
PRICE T ROWE ASSOCIATES INC /MD/ (Filed by)
| Form SC 13G/A
| |
02/12/2019
11:10 AM | Alexion Pharmaceuticals (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G/A
| |
02/11/2019
5:39 PM | Alexion Pharmaceuticals (Issuer)
HANTSON LUDWIG (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/11/2019
5:21 PM | Alexion Pharmaceuticals (Issuer)
Clancy Paul J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/11/2019
5:20 PM | Alexion Pharmaceuticals (Issuer)
Goff Brian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/11/2019
5:18 PM | Alexion Pharmaceuticals (Issuer)
Franchini Indrani Lall (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/11/2019
9:30 AM | Alexion Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A
| |
02/06/2019
8:03 AM | Alexion Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/04/2019
9:09 AM | Alexion Pharmaceuticals (Subject)
BlackRock Inc. (Filed by)
| Form SC 13G/A
| |
02/04/2019
5:37 AM | Alexion Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/03/2019
5:07 PM | Alexion Pharmaceuticals (Issuer)
HANTSON LUDWIG (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/21/2018
10:29 AM | Alexion Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/17/2018
11:00 AM | Alexion Pharmaceuticals (Filer)
| Form CT ORDER
| |
11/30/2018
5:15 PM | Alexion Pharmaceuticals (Issuer)
Franchini Indrani Lall (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/16/2018
5:10 AM | Alexion Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/13/2018
9:38 AM | Alexion Pharmaceuticals (Subject)
FMR LLC (Filed by)
| Form SC 13G/A
| |
10/24/2018
3:27 PM | Alexion Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/24/2018
5:46 AM | Alexion Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/01/2018
4:26 PM | Alexion Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/14/2018
4:20 PM | Alexion Pharmaceuticals (Filer)
| Form S-3ASR
| |
07/26/2018
3:40 PM | Alexion Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/26/2018
5:55 AM | Alexion Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/12/2018
4:23 PM | Alexion Pharmaceuticals (Issuer)
Clancy Paul J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2018
5:03 AM | Alexion Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/12/2018
3:52 PM | Alexion Pharmaceuticals (Issuer)
Franchini Indrani Lall (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2018
3:51 PM | Alexion Pharmaceuticals (Issuer)
LAW ANNE-MARIE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2018
3:51 PM | Alexion Pharmaceuticals (Issuer)
Goff Brian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2018
3:51 PM | Alexion Pharmaceuticals (Issuer)
ORLOFF JOHN J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2018
9:19 AM | Alexion Pharmaceuticals (Subject)
PRICE T ROWE ASSOCIATES INC /MD/ (Filed by)
| Form SC 13G/A
| |
05/11/2018
3:44 PM | 667, L.P. (Reporting)
Alexion Pharmaceuticals (Issuer)
Baker Bros. Advisors LLC (0001580575) (Reporting)
BAKER BROS. ADVISORS LP (Reporting)
Baker Brothers Life Sciences LP (Reporting)
BAKER FELIX (Reporting)
BAKER JULIAN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/11/2018
3:16 PM | Alexion Pharmaceuticals (Issuer)
Brennan David R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/11/2018
3:15 PM | Alexion Pharmaceuticals (Issuer)
Reinsdorf Judith A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/11/2018
3:14 PM | Alexion Pharmaceuticals (Issuer)
COUGHLIN CHRISTOPHER J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/11/2018
3:13 PM | Alexion Pharmaceuticals (Issuer)
Dunsire Deborah (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
